Ambea AB (CHIX:AMBEAS) EBITDA: kr3,033 Mil (TTM As of Mar. 2026)


CHIX:AMBEAS Ambea AB CHIX:AMBEAS
82 GF Score
Price kr140.40
GF Value kr110.05
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ambea AB EBITDA?

Ambea AB CHIX:AMBEAS 82 EBITDA is kr3,033 Mil as of Mar. 2026. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 82/100 and a GF Value™ of kr110.05 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Ambea AB's EBITDA for the three months ended in Mar. 2026 was kr758 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr3,033 Mil.

During the past 12 months, the average EBITDA Growth Rate of Ambea AB was 14.00% per year. During the past 3 years, the average EBITDA Growth Rate was 12.40% per year. During the past 5 years, the average EBITDA Growth Rate was 13.80% per year. During the past 10 years, the average EBITDA Growth Rate was 26.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 12 years, the highest 3-Year average EBITDA Growth Rate of Ambea AB was 53.70% per year. The lowest was 12.40% per year. And the median was 18.10% per year.

Ambea AB's EBITDA per Share for the three months ended in Mar. 2026 was kr9.28. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2026 was kr36.34.

During the past 12 months, the average EBITDA per Share Growth Rate of Ambea AB was 15.80% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 16.80% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 16.80% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 24.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 12 years, the highest 3-Year average EBITDA per Share Growth Rate of Ambea AB was 47.80% per year. The lowest was 10.90% per year. And the median was 21.20% per year.

Ambea AB  (CHIX:AMBEAs) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Ambea AB EBITDA Related Terms


Ambea AB EBITDA Historical Data

* Premium members only.

The historical data trend for Ambea AB's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambea AB EBITDA Chart

Ambea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,615.00 2,003.00 2,251.00 2,618.00 2,846.00

Ambea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 607.00 647.00 937.00 691.00 758.00

CHIX:AMBEAS vs HCA, THC, DVA: EBITDA Comparison

For the Medical Care Facilities subindustry, Ambea AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambea AB EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ambea AB's EV-to-EBITDA falls into.


CHIX:AMBEAS
82GF Score
Ambea AB CHIX:AMBEAS
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Ambea AB's EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Ambea AB's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2025, Ambea AB's EBITDA was kr2,846 Mil.

Ambea AB's EBITDA for the quarter that ended in Mar. 2026 is calculated as

Ambea AB's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2026, Ambea AB's EBITDA was kr758 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,033 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of kr3,033 Mil mean?
Ambea AB (CHIX:AMBEAS) has a EBITDA of kr3,033 Mil as of Mar. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Ambea AB.
Is Ambea AB's EBITDA too high?
Ambea AB's current EBITDA is kr3,033 Mil. Overall, Ambea AB has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's EBITDA compare to HCA and THC?
Ambea AB's EBITDA of kr3,033 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Healthcare Providers & Services company?
A good EBITDA depends on the Healthcare Providers & Services industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Ambea AB. Ambea AB's current EBITDA is kr3,033 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr110.05, compared to a current price of kr140.40 — trading 27.6% above its estimated fair value. The current EBITDA is kr3,033 Mil. Ambea AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current EBITDA is kr3,033 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?

Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued. The current stock price of kr140.40 is trading 27.6% above its estimated GF Value™ of kr110.05. GuruFocus considers Ambea AB to be Modestly Overvalued.

Key valuation signals for CHIX:AMBEAS:

  • EBITDA: kr3,033 Mil
  • GF Value™: kr110.05 vs. price of kr140.40 (27.6% above fair value)
  • GF Score™: 82/100 with 4 warning signs

No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambea AB Business Description

Address Rontgenvagen 3D, Box 1565, Solna, Stockholm, SWE, 171 29
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
82GF Score

Get the complete analysis for CHIX:AMBEAS

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr140.40
Price
kr110.05
GF Value